Core Insights - UnitedHealth Group's Optum Rx is modernizing pharmacy payments by adopting a cost-based reimbursement model, which aims to provide fairer payments to pharmacies and improve medication access for consumers [1][4] - The new model is particularly advantageous for independent and community pharmacies, ensuring financial stability and better medication stocks [2][3] - This initiative is expected to enhance pharmacy participation in Optum Rx's network, leading to improved service delivery and consumer satisfaction [3][4] Financial Outlook - Optum Rx's revenues are projected to be between $145.5 billion and $146.5 billion for 2025, with a long-term growth rate of 5-8% [4] - UnitedHealth Group's shares have increased by 4% over the past year, outperforming the industry's 3% decline [5] Market Position - The alignment of payment models with actual drug costs enhances Optum Rx's credibility and transparency, potentially attracting new clients [4] - Optum Rx's commitment to passing 100% of drug rebates to clients by 2028 positions it as a leader in ethical pharmacy management [4]

Core Viewpoint - Humana Inc. is expanding its CenterWell Senior Primary Care Centers, with a focus on providing accessible, value-based healthcare for seniors, particularly in underserved communities [1][3][4]. Group 1: Expansion and Accessibility - The grand opening of the CenterWell Senior Primary Care Center in Gladstone, MO, marks the beginning of a broader expansion, with plans for 22 additional centers at Walmart locations across four states by mid-2025 [1][2]. - The Gladstone facility began seeing patients in December, with further centers in Florida, Georgia, and Texas expected to open later this spring [2]. Group 2: Value-Based Care Model - Humana's value-based care model emphasizes preventive care, which has resulted in a 10% increase in primary care visits among patients in these models, leading to fewer hospital admissions and better management of chronic conditions [3][4]. - The company aims to strengthen its presence in the Medicare Advantage market, a significant revenue driver, by attracting more seniors to its network [4]. Group 3: Financial Performance - The CenterWell segment generated revenues of $5.1 billion in the fourth quarter of 2024, supported by expanding service lines and improved revenues from the Primary Care business [5]. - Humana's shares have seen a decline of 23.2% over the past year, contrasting with a 3% decline in the broader industry [6].

Core Insights - Humana Inc. has partnered with Icon Health to enhance access to musculoskeletal care for seniors through its CenterWell and Conviva primary care providers, launching in Palm Beach County [1][2] - This collaboration is expected to strengthen Humana's CenterWell segment, which reported an 8.9% year-over-year revenue increase in Q4 2024, and aims to simplify access to comprehensive treatment for musculoskeletal conditions [2][3] - The initiative aligns with Humana's commitment to value-based care, potentially reducing emergency room visits and hospital admissions, thereby improving patient health and operational efficiency [3][4] Company Performance - Humana's shares have increased by 12.1% over the past three months, outperforming the industry growth of 4.1% [5] Strategic Positioning - By integrating specialized care within primary care settings, Humana is well-positioned to attract more seniors seeking comprehensive healthcare solutions, supporting its long-term growth strategy [4]

Group 1 - Investors in Addus HomeCare Corporation (ADUS) should monitor the stock due to significant activity in the options market, particularly the Apr 17, 2025 $60.00 Put which has high implied volatility [1] - Implied volatility indicates the market's expectation of future price movement, suggesting that investors anticipate a significant change in Addus HomeCare's stock price, potentially due to an upcoming event [2] - Addus HomeCare currently holds a Zacks Rank 2 (Buy) in the Medical - Outpatient and Home Healthcare industry, which is in the top 21% of the Zacks Industry Rank [3] Group 2 - Over the past 60 days, no analysts have raised their earnings estimates for the current quarter, while one analyst has lowered the estimate, resulting in a decrease in the Zacks Consensus Estimate from $1.35 to $1.34 per share [3] - The high implied volatility may indicate a trading opportunity, as options traders often seek to sell premium on options with high implied volatility, hoping the stock does not move as much as expected by expiration [4]

Financial Data and Key Metrics Changes - Total revenue for Q4 2024 was $297.1 million, an increase of 7.5% compared to $276.4 million in Q4 2023 [20] - Adjusted earnings per share for Q4 2024 was $1.38, up 4.6% from $1.32 in Q4 2023 [20] - Adjusted EBITDA for Q4 2024 was $37.8 million, a 10.3% increase from $34.3 million in Q4 2023 [20] - For the full year 2024, total revenue was $1.2 billion, a 9.1% increase from $1.1 billion in 2023 [21] - Adjusted EBITDA for 2024 was $140.3 million, up 15.9% from $121 million in 2023 [21] Business Line Data and Key Metrics Changes - Personal care revenues for Q4 2024 were $216.9 million, accounting for 73.8% of total revenue [52] - Hospice care revenues were $59 million, representing 20.1% of total revenue [52] - Home health revenues were $17.8 million, making up 6.1% of total revenue [52] - Same store revenue growth for personal care was 5.8% in Q4 2024 compared to Q4 2023 [35] - Hospice same store revenue increased by 7.8% year-over-year [37] - Home health segment returned to positive growth with a 1.6% increase compared to Q4 2023 [39] Market Data and Key Metrics Changes - Illinois enacted a 5.5% rate increase for personal care services effective January 1, 2025, expected to contribute approximately $23 million in annualized revenue [34][47] - The company experienced solid caregiver hiring success, with personal care hiring at 76 hires per day, up from 74 hires per day in Q4 2023 [30] Company Strategy and Development Direction - The company is focused on expanding services related to home care, which is seen as valuable to both states and Congress [18] - The Gentiva acquisition is a significant part of the growth strategy, adding approximately $280 million in annualized revenues [50] - The company aims for a targeted minimum annual revenue growth of 10% despite the larger revenue base [40] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism regarding the potential impact of Medicaid program changes, believing that their services reduce overall costs to state Medicaid programs [16][19] - The company is well-positioned to handle potential changes in Medicaid funding due to its low-cost provider status [99] - Management anticipates continued growth in personal care services, aiming for a revenue increase of 3% to 5% in 2025 [72] Other Important Information - The company had cash on hand of approximately $100 million as of the end of 2024 [22] - A one-time write-off of approximately $4.9 million was taken in Q4 2024 related to excess corporate office space [29] - The company maintains a conservative leverage position at just under one times Adjusted EBITDA, allowing flexibility for strategic acquisitions [23] Q&A Session Summary Question: Average revenue per hour in Q4 and its impact - The average revenue per hour is expected to be slightly down due to the Gentiva deal and the lower reimbursement rate in Texas [67] Question: Organic volume growth in personal care - Organic volume growth in personal care was slightly up, with expectations to reach the higher end of the 3% to 5% growth range in 2025 [72][74] Question: Impact of work requirements on business - The majority of clients served are elderly and disabled, so work requirements would have negligible direct effects, potentially increasing caregiver availability [83] Question: Integration of Gentiva and its impact on cash flow - The integration of Gentiva is progressing smoothly, with no significant impact on cash flow conversion expected [119] Question: Expected margin decline from Q4 to Q1 - A 200 basis point margin decline is anticipated, primarily due to the mix shift from Gentiva and annual resets of payroll taxes [54][109]

Table of Contents As filed with the Securities and Exchange Commission on January 17, 2024 Registration No. 333-276348 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BrightSpring Health Services, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 8082 82-2956404 (I ...